Literature DB >> 26141436

MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum.

Daoyu Yang1, Jing Liu, Pan Hao, Jing Wang, Tao Lei, Dan Shan, Qun Liu.   

Abstract

Microneme protein 3 (MIC3) is an important adhesion molecule expressed by Toxoplasma gondii and Neospora caninum that plays a crucial role in invasion. In our study, we found that recombinant TgMIC3 (rTgMIC3) was recognized by both T. gondii-reactive sera and hyper-immune serum against N. caninum. Polyclonal antibodies against TgMIC3 reacted with N. caninum by western blot and immunofluorescence assay (IFA). These results indicate that MIC3 is a novel cross-reactive antigen expressed in N. caninum and T. gondii. To evaluate the immune-protective effect of TgMIC3, we created the eukaryotic expression vector pcDNA3.1-TgMIC3, transfected this vector into HEK293T cells by lipofection, and evaluated TgMIC3 expression in HEK293T cells using western blot and IFA. Then, groups of BALB/c mice were immunized with recombinant TgMIC3 protein, pcDNA3.1-TgMIC3, or two-vaccine immunization. The mice were challenged with T. gondii RH or N. caninum Nc-1 tachyzoites 14 days after the final immunization. The survival time of T. gondii-infected mice was recorded, and the parasite burden in the brain of N. caninum-infected mice 30 days post-infection was measured using real-time PCR. The results demonstrated that mice immunized with TgMIC3-based vaccines elicited high antibody titers. After parasitic challenge, mice immunized with pcDNA-TgMIC3 exhibited prolonged survival when infected with T. gondii tachyzoites and a lower parasitic burden in the brains of mice challenged with N. caninum tachyzoites. These results demonstrate that TgMIC3 is a cross-protective antigen expressed in T. gondii and N. caninum and could elicit some protection against toxoplasmosis and neosporosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26141436     DOI: 10.1007/s00436-015-4609-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  19 in total

1.  Characterization of microneme proteins of Toxoplasma gondii.

Authors:  A Achbarou; O Mercereau-Puijalon; J M Autheman; B Fortier; D Camus; J F Dubremetz
Journal:  Mol Biochem Parasitol       Date:  1991-08       Impact factor: 1.759

2.  Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.

Authors:  Anahi Fernandez Cuppari; Vanesa Sanchez; Bibiana Ledesma; Fernanda M Frank; Alejandra Goldman; Sergio O Angel; Valentina Martin
Journal:  Vaccine       Date:  2008-08-21       Impact factor: 3.641

Review 3.  The moving junction, a key portal to host cell invasion by apicomplexan parasites.

Authors:  Bang Shen; L David Sibley
Journal:  Curr Opin Microbiol       Date:  2012-03-23       Impact factor: 7.934

4.  Identification and characterization of cross-reactive antigens from Neospora caninum and Toxoplasma gondii.

Authors:  M Liao; X Xuan; X Huang; H Shirafuji; S Fukumoto; H Hirata; H Suzuki; K Fujisaki
Journal:  Parasitology       Date:  2005-05       Impact factor: 3.234

5.  Development of rapid immunochromatographic test with recombinant NcSAG1 for detection of antibodies to Neospora caninum in cattle.

Authors:  Min Liao; Shoufa Zhang; Xuenan Xuan; Guohong Zhang; Xiaohong Huang; Ikuo Igarashi; Kozo Fujisaki
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

6.  Identification of the cross-reactive and species-specific antigens between Neospora caninum and Toxoplasma gondii tachyzoites by a proteomics approach.

Authors:  Houshuang Zhang; Eung-Goo Lee; Longzheng Yu; Suguru Kawano; Penglong Huang; Min Liao; Osamu Kawase; Guohong Zhang; Jinlin Zhou; Kozo Fujisaki; Yoshifumi Nishikawa; Xuenan Xuan
Journal:  Parasitol Res       Date:  2011-04-02       Impact factor: 2.289

Review 7.  Comparison of the major antigens of Neospora caninum and Toxoplasma gondii.

Authors:  D K Howe; L D Sibley
Journal:  Int J Parasitol       Date:  1999-10       Impact factor: 3.981

8.  First isolation of Neospora caninum from blood of a naturally infected adult dairy cow in Beijing, China.

Authors:  Pan Hao; Na Yang; Xia Cui; Jing Liu; Daoyu Yang; Qun Liu
Journal:  J Parasitol       Date:  2014-12       Impact factor: 1.276

9.  Molecular signals in the trafficking of Toxoplasma gondii protein MIC3 to the micronemes.

Authors:  Hiba El Hajj; Julien Papoin; Odile Cérède; Nathalie Garcia-Réguet; Martine Soête; Jean-François Dubremetz; Maryse Lebrun
Journal:  Eukaryot Cell       Date:  2008-04-04

10.  A family of transmembrane microneme proteins of Toxoplasma gondii contain EGF-like domains and function as escorters.

Authors:  Markus Meissner; Matthias Reiss; Nicola Viebig; Vern B Carruthers; Catherine Toursel; Stanislas Tomavo; James W Ajioka; Dominique Soldati
Journal:  J Cell Sci       Date:  2002-02-01       Impact factor: 5.285

View more
  8 in total

1.  The p38 MAPK inhibitor, SB203580, inhibits cell invasion by Neospora caninum.

Authors:  Xiaoxia Jin; Pengtao Gong; Guojiang Li; Xichen Zhang; Jianhua Li
Journal:  Parasitol Res       Date:  2016-12-30       Impact factor: 2.289

2.  A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles.

Authors:  Ying Xu; Nian-Zhang Zhang; Meng Wang; Hu Dong; Sheng-Yong Feng; Hui-Chen Guo; Xing-Quan Zhu
Journal:  Parasitol Res       Date:  2015-08-06       Impact factor: 2.289

3.  Immunogenicity and protection efficacy of enhanced fitness recombinant Salmonella Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis.

Authors:  Fei-Kean Loh; Sheila Nathan; Sek-Chuen Chow; Chee-Mun Fang
Journal:  Pathog Glob Health       Date:  2021-02-01       Impact factor: 2.894

4.  Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis.

Authors:  Won Hyung Choi; Ji Sun Park
Journal:  Biomedicines       Date:  2020-04-18

Review 5.  Recent progress in microneme-based vaccines development against Toxoplasma gondii.

Authors:  Masoud Foroutan; Leila Zaki; Fatemeh Ghaffarifar
Journal:  Clin Exp Vaccine Res       Date:  2018-07-31

6.  Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB/c mice.

Authors:  Fatemeh Ghaffarifar; Mohammad Jafarimodrek; Hossein Vazini; Zohreh Sharifi; Abdolhossein Dalimi; Mohammad Saaid Dayer
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

7.  Evaluation of 4 merozoite antigens as candidate vaccines against Eimeria tenella infection.

Authors:  Xingju Song; Xu Yang; Taotao Zhang; Jing Liu; Qun Liu
Journal:  Poult Sci       Date:  2020-12-10       Impact factor: 3.352

8.  Activation of a Neospora caninum EGFR-Like Kinase Facilitates Intracellular Parasite Proliferation.

Authors:  Xiaoxia Jin; Guojiang Li; Xichen Zhang; Pengtao Gong; Yanhui Yu; Jianhua Li
Journal:  Front Microbiol       Date:  2017-10-12       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.